Concepedia

J. Fryklund

JF

Statistics

Publications

16

Citations

742

H-Index

13

Active since

1984

Affiliations

AstraZeneca (Sweden)(Current)

J. Fryklund is an author at AstraZeneca (Sweden) specializing in pharmacology, gastrointestinal pharmacology, and enzymology.

Publications per year

1984–2000

16

Publications

16

Inhibition of gastric H+,K+-ATPase and acid secretion by SCH 28080, a substituted pyridyl(1,2a)imidazole.

B. Wallmark, Carin Briving, J. Fryklund et al. · Journal of Biological Chemistry · 1987 · 232 citations · Full text

Medicine, Biochemistry, Pharmacology +13

Structure-Activity Relationship of Omeprazole and Analogs as Helicobacter pylori Urease Inhibitors

Thomas C. Kühler, J. Fryklund, J Weilitz · Journal of Medicinal Chemistry · 1995 · 91 citations

Life Sciences, Biochemistry, Pharmacology +16

Gamma‐Interferon‐Mediated Down‐Regulation of Electrolyte Secretion by Intestinal Epithelial Cells: A Local Immune Mechanism?

Jan Holmgren, J. Fryklund, Håkan Larsson · Scandinavian Journal of Immunology · 1989 · 69 citations

Life Sciences, Immunology, Physiology +17

Rat parietal cell function after prolonged inhibition of gastric acid secretion

Håkan Larsson, Enar Carlsson, B. Ryberg et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 1988 · 66 citations

Medicine, Pharmacology, Physiology +15

Specific labelling of gastric H+,K+-ATPase by omeprazole

J. Fryklund, Karin Gedda, B. Wallmark · Biochemical Pharmacology · 1988 · 52 citations

Life Sciences, Biochemistry, Pharmacology +14

1–5 of 16